Cohen Neil Harris bought CMMB
March 18, 2024 · Form 4 insider transaction
Cohen Neil Harris bought 2,520 shares of Chemomab Therapeutics Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 897 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,520
Price
$0.00
Total value
N/A
InsiderCohen Neil Harris
Role—
SecurityStock option (right to buy American Depositary Shares)
Transaction codeA: Grant or award
Transaction dateMarch 18, 2024
Filing dateSeptember 1, 2026
Shares owned after9,082
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options reported in this row were granted to the Reporting Person by the Issuer on March 18, 2024, and are fully vested and exercisable as of the date of this report.